baber/WOPTO huggingface dataset:
Patent EP-1935433-A1 (EP)
Inventor: LEE TE-WEI
IPC: A61K47/48
Filed: 2006-12-13
Abstract: The present invention discloses a method for preparing lipid-spacer-reactive functional group-peptide, wherein 
the peptide consists of 3 to 16 amino acid residues in which at least one amino acid residue is lysine (Lys), 
the reactive functional group is a formula of -X-CO-Y-CO-, wherein X represents an oxygen atom or a nitrogen atom, and Y represents C 1-6  alkylene which may be interrupted by one or two oxygen or nitrogen atom(s), 
the spacer is a hydrophilic polymer, and 
the lipid is phosphatidylethanoaminecarbonyl represented by the formula (I):
     
R 1  and R 2  are the same or different and individually represent linear or branch C 7-30  alkyl or linear or branch C 7-30  alkenyl; which is characterized in that the reaction is carried out in a liquid phase and comprises the following steps of (a) firstly protecting Lys amino acid residue in the peptide through a protection group; (b) subsequently reacting the peptide with the lipid-spacer-reactive functional group; and (c) finally removing the protection group from Lys amino acid residue in the peptide.
Patent EP-1798402-A1 (EP)
Inventor: SUZUKI KUNIHIKO
IPC: F02D37/02
Filed: 2006-12-19
Abstract: At the present invention, a transient correction of an ignition timing is precisely executed even in a transient state. The ignition timing at a stationary time is computed on the basis of an operating state detected by an operating state detecting means (101), and the ignition timing at the stationary time is corrected by a transient time ignition timing correcting means (104) defined by a transfer function G(s).
Patent EP-1897530-A1 (EP)
IPC: A61K8/49
Filed: 2006-12-20
Abstract: The present invention relates to an oral composition containing an optimal combination of nutritional ingredients at high concentrations and at optimal ratios in order to maintain and/or achieve health and/or beautiful look of the skin.
Patent EP-1681373-A1 (EP)
Inventor: FERRIER DONALD
IPC: C09D201/00
Filed: 2001-05-01
Abstract: A composition and process are described which are useful in treating metal surfaces, which composition comprises an oxidizer, an acid, a corrosion inhibitor, an organic nitro compound and, optionally, a benzotriazole with an electron withdrawing group in the 1-position which electron withdrawing group is a stronger electron withdrawer than a hydrogen group, optionally, a source of adhesion enhancing species selected from the group consisting of molybdates, tungstates, tantalates, niobates, vanadates, isopoly or heteropoly acids of molybdenum, tungsten, tantalum, niobium, vanadium, and combinations of any of the foregoing and optionally by preferably a source of halide ions. The composition and process are useful in increasing the adhesion of metal surfaces to polymeric substances and in preserving said adhesion through temperature variation.
Patent EP-1721512-A1 (EP)
Inventor: KEMPF GUENTER
IPC: A01D57/20
Filed: 2006-05-04
Abstract: The unit has frames that are fastened at a screw-conveyor extending transverse to forward direction of the unit. The frames are prearranged in forward direction of assemblies with conveyor belts (98). The conveyor belts convey harvest crop backward to the screw-conveyor. Covers (90) exist between the assemblies for sealing inner space of the assemblies. The conveyor belts lie upstream to the covers with respect to harvest crop that is transported transverse to the forward direction. The conveyor belts project in their area, which is directly proximate to the covers, over the adjacent cover.
Patent EP-1875934-A1 (EP)
IPC: A61M5/19
Filed: 2006-07-06
Abstract: A drug expelling medical device has a drug storage chamber (1) and a drug pressure chamber (2). The drug contained in the storage chamber is transferred via a transfer channel (9) to the pressure chamber by moving a slidable plunger (5) forming a liquid barrier between the two chambers in a first direction, whereby the volume of the storage chamber is decreased and the volume of the pressure chamber is correspondingly increased. The plunger is sealed towards the chamber wall(s) and an optional orifice in the pressure chamber can be sealed off prior to the drug expelling.
Patent EP-1788454-A1 (EP)
Inventor: PATEL RAJ D
IPC: G03G9/087
Filed: 2006-09-19
Abstract: Embodiments include a distilled wax having a crystallinity of from about 55 to about 100 percent, wherein the degree of crystallinity is calculated using the following formulas: [Heat of enthalpy (Hm) J/g / 294 J/g] x 100 = degree of crystallinity (Xc); [Heat of recrystallization (Hrc) J/g / 294 J/g] x 100 = degree of crystallinity (Xc); and Sc/(Sc+Sa)] x 100%, wherein Sc is a diffraction peak area of a crystalline component of the wax and the Sa is a diffraction peak area of an amorphous component of the wax; and wherein the Mp, Mn and Mw of the wax are all within the range of from about 500 to about 800, and wherein the wax has a polydispersity of from about 1 to about 1.05.
Patent EP-1731408-A1 (EP)
Inventor: KATO HIROAKI
IPC: B62D5/04
Filed: 2005-04-05
Abstract: A vehicle steering apparatus for improving steering feel when changing the angle of a steered wheel with a motor. An IFS torque compensation unit includes an oversteer IFS torque compensation gain calculation unit, which obtains a larger IFS torque compensation gain as a control target element increases during oversteer control. When an oversteer state occurs, the IFS torque compensation control unit outputs a corrected gain, which is based on the IFS torque compensation gain.
Patent EP-1770157-A1 (EP)
Inventor: CARVELL MELVIN
IPC: C11D3/22
Filed: 2004-05-17
Abstract: A water-soluble or dispersible, hydrolytically stable polysaccharide selected from the group consisting galactomannan, xylo-glucan or a mixture thereof. Which is covalently linked by a hydrolytically stable bond to a first polymeric textile softening species (typically a silicone) and optionally emulsified with a second polymeric textile softening species. The specification also discloses laundry treatment composition comprising these compositions.
Patent EP-1788663-A1 (EP)
Inventor: ISHIMIYA KATSUNORI
IPC: H01Q1/24
Filed: 2006-11-17
Abstract: Disclosed is a folded dipole antenna device which is of an unbalanced feed type and includes an antenna element of approximately plate-like loop structure, connected to an antenna feed point (1) and an antenna ground (2) provided on a base plate (4). In the folded dipole antenna device, the antenna element of loop structure includes a pair of first element sections (3g, 3f) which extend approximately parallel to the base plate (4), a second element section formed by merging element sections (3c, 3d) that are folded back from both ends of the first element sections (3g, 3f) and extend approximately parallel to the first element sections (3g, 3f), and a third element section (3a) which extends from a folded top part of the second element section toward the first element sections (3g, 3f) and an end part thereof is close to the first element sections (3g, 3f).
Patent EP-1739885-A1 (EP)
Inventor: KNECKT JARKKO
IPC: H04L12/56
Filed: 2006-06-30
Abstract: A system and method for more efficiently scheduling and implementing unscheduled automatic power save delivery service periods between a terminal and an access point. An triggering interval is set for an untrigger flag, the untrigger flag not permitting the implementation of an automatic power save delivery period. Automatic triggering is used unless a plurality of criteria are met, in which case the triggering interval is calculated based upon a plurality of variables. Untrigger flags are set for selected frames based upon the triggering interval, and unscheduled automatic power save delivery service periods are implemented for frames for which the untrigger flag is not set and for which the terminal receives an indication of additional data from a remote source such as an access point.
Patent EP-1806398-A1 (EP)
Inventor: DESPEGHEL JEAN-PIERRE
IPC: C12N9/02
Filed: 2006-01-04
Abstract: The present invention relates to plants, seeds and products derived thereof, in particular to Brassica plants, seeds products derived thereof, that have mutant sequences conferring high oleic acid profile on the seed oil. 
     More particularly, the invention relates to mutant delta-12 fatty acid desaturase sequences, also referred to herein as FAD2 sequences, in such plants which confer high oleic acid profile on the seed oil
Patent EP-1790785-A1 (EP)
Inventor: GAUCHERAND JEAN-FRANCOIS
IPC: E04B1/343
Filed: 2006-11-22
Abstract: The structure (1) has covering modules (M1, M2) overlapping each other and linearly deployed to totally/partially cover an area to be sheltered. Connection units are mounted between the modules for automatic linear deployment of the modules after releasing a retaining unit of the modules in overlapped position. The retaining unit has a traction rope (13) wound using a manual or motorized winch (14). The connection units have articulated arms (7, 8) in combination with an elastic unit (9) e.g. spring, chosen to exert a pushing force for deployment of the arms.
Patent EP-1757859-A1 (EP)
Inventor: EISENZOPF GEORG
IPC: F23B80/04
Filed: 2006-08-22
Abstract: The boiler has a feeding device (8) provided at a front wall (7) of a combustion chamber (1) to discharge the fuel on a grid. The feeding device includes a blower (10) with a suction pipe (11) that is provided with an air control valve (13), where a dosing screw (9) for the fuel opens out into the pipe. An exhaust gas discharge opening (2) is provided in an area of blower-side front wall in a cover (16) of the chamber. A front wall (14) facing the blower forms a conduction surface (15) for directing the exhaust gas along the cover to the opening (2).
Patent EP-1838651-A1 (EP)
Inventor: DALLORO LEONARDO
IPC: B01J23/31
Filed: 2006-01-10
Abstract: La présente invention a trait à un procédé pour la préparation de phénol par l'hydrodésoxygénation de dérivés du benzène polyhydroxylés pour l'hydroxylation sélective du benzène dans des conditions d'appauvrissement. Le procédés est caractérisé en ce que lesdites réactions sont effectuées en présence d'un catalyseur à base d'oxydes métalliques à constituants multiples comprenant au moins un métal choisi parmi les groupes VB, VIB, VIII, IB, IIB, IVA, VA.
Patent EP-1844529-A1 (EP)
Inventor: CHAZOTTES FREDERIC
IPC: H01R13/629
Filed: 2006-01-18
Abstract: The inventive electric connector comprises an insulating casing (13) provided with dimples (15) for receiving respective contacts connected to cables (40), a cap (17) which forms a guide for said cables and is arranged and fixed to the casing (13), a manoeuvring member (19) which movably mounted on an assembly formed by the casing (13) and the cap (17) for interacting in a clutch manner with an additional member placed on the counter part of the connector in order to ensure the coupling and decoupling of the connector and the counter part thereof. Said manoeuvring member (19) is movably mounted on the cap (17). A method for assembling the inventive connector is also disclosed.
Patent EP-1858501-A1 (EP)
Inventor: FERNANDEZ-TRESGUERRES JESUS AN
IPC: A61K31/155
Filed: 2006-02-27
Abstract: La présente invention a trait à l'utilisation d'un antagoniste de récepteur NMDA, de préférence la mémantine ou le néramexane ou un sel ou un prodrogue pharmaceutiquement acceptable desdits antagonistes, dans la préparation d'une composition pharmaceutique pour la prévention, l'amélioration et/ou le traitement de troubles du métabolisme influençant le poids corporel, notamment l'obésité, un trouble de l'alimentation et/ou dans la régulation de l'appétit. L'invention a également trait à un procédé pour la prévention, l'amélioration et/ou le traitement de troubles du métabolisme influençant le poids corporel, notamment l'obésité, un trouble de l'alimentation et/ou dans la régulation de l'appétit comprenant l'étape d'administration à un sujet qui en a besoin d'une quantité thérapeutiquement efficace d'un antagoniste de récepteur NMDA, de préférence la mémantine ou le néramexane ou un sel ou prodrogue pharmaceutiquement acceptable desdits antagonistes.
Patent EP-1861473-A1 (EP)
Inventor: LETTMANN BERNHARD
IPC: C09D133/04
Filed: 2006-01-25
Abstract: Integriertes Beschichtungsstoffsystem, umfassend (I) mindestens ein von deckenden Pigmenten freies, thermisch oder thermisch und mit UV-A-Strahlung härtbares, lösemittelhaltiges Beschichtungsstoffsystem, umfassend (1.1) mindestens eine separate, von Isocyanatgruppen freie Komponente, enthaltend isocyanatreaktive funktionelle Gruppen, und (1.2) mindestens eine separate, von isocyanatreaktiven funktionellen Gruppen freie Komponente, enthaltend Isocyanatgruppen, wobei keine der Komponenten (1.1) und (I.2) oder mindestens eine der Komponenten (1.1) und/oder (1.2) mindestens einen mit UV-A-Strahlung härtbaren Bestandteil aufweist; sowie (II) mindestens einen separaten, von deckenden Pigmenten und Isocyanatgruppen freien, mit UV-A-Strahlung härtbaren, Lösemittel und isocyanatreaktive funktionelle Gruppen enthaltenden Beschichtungsstoff; wobei die mit UV-A-Strahlung härtbaren Bestandteile in Kombination mit mindestens einem farblosen oder im Wesentlichen farblosen Photoinitiator mit mindestens einem Absorptionsmaximum im Wellenlängenbereich von λ = 300 bis 400 nm vorliegen; Verfahren zu seiner Herstellung und seine Verwendung.
Patent EP-1853894-A1 (EP)
Title: Dispositif de mesure du stress oxydatif et methodes associees
Inventor: ROSENDAHL SCOTT
IPC: A61B5/00
Filed: 2006-02-21
Abstract: L'invention concerne la mesure d'un composant de stress oxydatif chez un patient. Un dispositif d'analyse optique comprenant une source de lumière et un détecteur de lumière est utilisé pour mesurer une propriété optique d'un milieu et pour générer des données de mesure optique. Un processeur analyse les données de mesure optique et génère une valeur pour un ou plusieurs composants de stress oxydatif sous forme d'une signature d'oxydo-réduction pour le patient. Des données de probabilité concernant la présence d'une maladie associée au stress oxydatif peuvent être calculées. En observant au moins une condition clinique supplémentaire de la maladie, un diagnostic peut être établi à l'aide de ladite condition supplémentaire et de ladite signature d'oxydo-réduction, par exemple la maladie d'Alzheimer, une légère déficience intellectuelle ou une déficience intellectuelle vasculaire.
Patent EP-1871148-A1 (EP)
Inventor: HATANO TAKAHISA
IPC: H05B41/392
Filed: 2006-01-18
Abstract: A PWM generation circuit is set so as to generate a PWM pulse signal having a frequency that is an odd number times a vertical synchronization frequency. A frequency division circuit frequency-divides the PWM pulse signal generated by the PWM generation circuit. An AND gate calculates the logical product of the PWM pulse signal generated by the PWM generation circuit and a frequency-division pulse signal outputted from the frequency division circuit. An OR gate calculates the logical sum of the PWM pulse signal generated by the PWM generation circuit and the frequency-division pulse signal outputted from the frequency division circuit. A selector outputs an output signal of the OR gate as a dimming pulse signal in a case where the set duty ratio is not less than 50 %, while outputting an output signal of the AND gate as a dimming pulse signal in a case where the set duty ratio is less than 50 %. Consequently, the frequency of the dimming pulse signal is five-second the frequency of a vertical synchronizing signal.
Patent EP-1864128-A1 (EP)
Inventor: MAC DONALD JOHN GAVIN
IPC: C12Q1/04
Filed: 2006-01-19
Abstract: La présente invention concerne une technique pour détecter la présence de micro-organismes d'une manière simple, rapide et efficace. Plus spécifiquement, la technique implique l'identification d'un ou de plusieurs composés volatils associés à un micro-organisme d'intérêt particulier. Les composés volatils peuvent être identifiés, par exemple, au moyen d'une micro-extraction en phase solide en conjonction avec des procédés d'analyse par chromatographie gazeuse / spectroscopie de masse ('GC/MS'). Après identification, un indicateur conçu pour subir un changement de couleur détectable en la présence du/des composé(s) volatil(s) identifié(s), peut être sélectionné. Si souhaité, l'indicateur peut être disposé sur un substrat pour former une bande d'indicateur à utiliser dans une large gamme d'applications. De cette manière, la présence du micro-organisme peut être détectée rapidement par simple observation d'un changement de couleur de la bande d'indicateur.
Patent EP-1858954-A1 (EP)
Inventor: NG HOWARD C
IPC: C08G65/336
Filed: 2006-02-21
Abstract: Homopolyéther ou copolyéther de polytriméthylène contenant du silicium, au moins une partie des groupes terminaux dudit polymère étant des groupes terminaux contenant du silicium ayant la formule : ―OSi(X)(Y)(Z), où X et Y sont des groupes qui sont facilement libérables du silicium par réaction avec de l'eau et/ou des alcools et Z est sélectionné dans le groupe constitué (a) de groupes alkyles linéaires ou ramifiés en C1-C20, (b) de groupes cycloaliphatiques, (c) de groupes aromatiques, chacun de (a), (b) et (c) étant facultativement substitué par un élément sélectionné dans le groupe constitué de O, N, P et S, (d) d'un hydrogène et (e) de groupes qui sont facilement libérables du silicium par de l'eau et/ou un alcool.
Patent EP-1864446-A1 (EP)
Inventor: WENIGER KILIAN
IPC: H04L47/2491
Filed: 2006-03-14
Abstract: A method and apparatus for improved context transfer in heterogeneous networks is presented. Context information is collected from source entities in a first access network by a context transfer manager and transmitted to a context transfer manager of a second access network which forwards the context information to target entities therein, in one of the context transfer managers at least a part of the context information is translated from a format supported in the first access network to another format supported in the second access network. The method may be carried out proactively preceding a handover or reactively following a handover. In one embodiment, context transfer within one access domain is performed directly between access routers, whereas context transfer between different access domains is performed via the context managers. In another embodiment, beacons from access points are counted in order to determine candidates for a pending handover.
Patent EP-1875674-A1 (EP)
Inventor: GOTTSWINTER WOLFGANG
IPC: B60R21/01
Filed: 2006-03-28
Abstract: L'invention concerne un procédé pour transmettre des données sur une ligne de données (12) entre un appareil de commande (10) central et au moins un appareil de traitement de données (11.1,11.2,11.3) décentralisé. Selon ce procédé, l'appareil de commande (10) central, en mode de fonctionnement normal, envoie périodiquement des impulsions de synchronisation (Sync) à l'appareil de traitement de données (11.1,11.2,11.3) par l'intermédiaire de la ligne de données (12) pour demander des paquets de données et l'appareil de traitement de données (11.1,11.2,11.3) décentralisé envoie ses données à envoyer, sous forme de paquets de données, à l'appareil de commande (10) central après l'impulsion de synchronisation (Sync). Chaque appareil de traitement de données (11.1,11.2,11.3) décentralisé est configuré par l'appareil de commande (10) central avant la première transmission de paquets de données à ce dernier. Une communication bidirectionnelle entre l'appareil de commande (10) central et l'appareil de traitement de données (11.1,11.2,11.3) décentralisé est réalisé pour configurer l'ensemble.
Patent EP-1863208-A1 (EP)
Inventor: MAEDA NORIYUKI
IPC: H04B7/04
Filed: 2006-03-20
Abstract: A disclosed receiver (200) in a MIMO multiplexing communication system (50), in which plural signals are simultaneously transmitted from plural transmitting antenna branches (101~104) using the same frequency, and the transmitted signals are retrieved by receiving signals at plural receiving antennas (201~204), separating the received signals and searching for proper symbol metrics for each branch, comprises a QR decomposer (230) for QR decomposing the received signals to orthogonalize the transmitted signals; a symbol replica candidate ranking unit (251) for subtracting surviving symbol replica candidates from the QR decomposed received signals to get remaining received signals and rank the remaining signals in the increasing order of expected branch metrics of the remaining received signals; a symbol replica candidate selector (252) for selecting symbol replica candidates in the ranked order; a branch metric calculator (253) for calculating the branch metrics of the selected symbol replica candidates; and a threshold comparator (254) for comparing the calculated branch metrics with a predetermined threshold; wherein if a calculated branch metric is larger than the predetermined threshold, the branch metric and successive branch metrics are deleted without further searching.
Patent EP-1864684-A1 (EP)
Inventor: KOKUBO TADASHI
IPC: A61L27/56
Filed: 2006-03-22
Abstract: An artificial bone which is excellent in the ability to form bone in a living body, reliably thereof, and has high mechanical strength. The process comprises the steps of: mixing granules, composed of a titanium or a titanium alloy powder and an organic binder, with a particulate pore-forming material, pressure-molding the mixture to obtain a molded body, firing the molded body at 1200°C to obtain a porous body, bringing the porous body into contact with an aqueous alkali solution, subsequently with water of 35 °C or higher for a period longer than that of contacting with the aqueous alkali solution and then heating the porous body at 100 to 650 °C, preferably 200 to 600 °C.
Patent EP-1849145-A1 (EP)
Title: Techniques pour reduire les fausses alarmes, la desactivation d'une securite non valide et le vol interne
Inventor: MAITLIN STEVEN
IPC: G08B13/24
Filed: 2006-02-09
Abstract: L'invention concerne un système, un appareil et un article permettant d'éliminer les fausses alarmes, la désactivation d'une sécurité non valide et le vol interne. L'appareil comprend une première entrée destinée à recevoir un premier code d'identification associé à un article, une seconde entrée destinée à recevoir un second code d'identification associé à l'article, ainsi qu'une sortie destinée à fournir un signal de commande permettant de commander le fonctionnement d'un dispositif de détection et de désactivation d'une étiquette de sécurité en fonction des premier et second codes d'identification. L'invention concerne également d'autres modes de réalisation.
Patent EP-1896133-A1 (EP)
Inventor: MCINTYRE JON T
IPC: A61N7/00
Filed: 2006-02-22
Abstract: Selon la présente invention, un mode de réalisation comprend la fourniture d’un dispositif médical comprenant une partie allongée et une partie distale, la partie distale comprenant une pluralité de cristaux sensiblement plats configurés pour émettre de l’énergie vers un point focal commun. Le dispositif médical peut être avancé dans une lumière corporelle, de l’énergie peut être fournie à un tissu corporel par l'intermédiaire des cristaux sensiblement plats et le dispositif médical peut être retiré de la lumière corporelle.
Patent EP-1875413-A1 (EP)
Inventor: BERKLEY ANDREW J
IPC: H01L39/22
Filed: 2006-04-26
Abstract: L'invention concerne des systèmes et des procédés pour copier l'état classique d'un bit quantique source vers un bit quantique cible. Ces techniques peuvent être utilisées pour lire les états d'une rangée de bits quantiques.
Patent EP-1876175-A1 (EP)
Inventor: KIMURA TAKAHITO
IPC: A61K9/00
Filed: 2006-04-27
Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.